January 2023
1/12/23
Presented by Winson Cai
“Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity.”
1/19/23
Presented by Stephanie Pierre
“Non-viral precision T cell receptor replacement for personalized cell therapy.”
1/26/23
Presented by James Han
“PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer”
February 2023
2/2/23
Presented by Chris Bourne
“SARS-CoV-2 Omicron subvariants evolved to promote further escape from MHC-I recognition.”
2/16/23
Presented by Patrick Wallisch
“Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity.”
2/23/23
Presented by Michael Lau
“Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy.”
March 2023
3/2/23
Presented by Skylar Lin
“Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance.”
3/16/23
Presented by Keifer Kurtz
“Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.”
3/30/23
Presented by Manish Malviya
“IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models.”
April 2023
4/13/23
Presented by Kristen Vogt
” Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastoma”
“GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma”
4/20/23
Presented by Pedro Silberman
“Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance.”
May 2023
5/4/23
Presented by Zita Aretz
” The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer”
5/11/23
Presented by Josh Lee
“Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements”
June 2023
6/1/23
Presented by Winson Cai
“Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer”
6/15/23
Presented by Stephanie Pierre
“Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomar”
July 2023
7/27/23
Presented by Patrick Wallisch
”CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours”
August 2023
8/10/23
Presented by Manish Malviya
”Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy”
September 2023
9/21/23
Presented by Winson Cai
“Epitope editing enables targeted immunotherapy of acute myeloid leukaemia”
9/25/23
Presented by Stephanie Pierre
“Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy”
December 2023
12/6/23
Presented by Annelisa Cornel
“Harnessing CD3 diversity to optimize CAR T cells”
12/14/23
Presented by Qianqian Lin
“Probiotic-guided CAR-T cells for solid tumor targeting”